DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing.
EBioMedicine
; 52: 102625, 2020 Feb.
Article
in En
| MEDLINE
| ID: mdl-31981978
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Lymphocyte Activation
/
T-Lymphocytes
/
CD3 Complex
/
Antibodies, Bispecific
/
Antigens, CD20
/
Cytotoxicity, Immunologic
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
EBioMedicine
Year:
2020
Type:
Article
Affiliation country:
Netherlands